These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nanotechnological applications for the treatment of neurodegenerative disorders. Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920 [TBL] [Abstract][Full Text] [Related]
4. Treatment of neurodegenerative disorders with radical nanomedicine. Singh N; Cohen CA; Rzigalinski BA Ann N Y Acad Sci; 2007 Dec; 1122():219-30. PubMed ID: 18077575 [TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of neurodegenerative disorders employing nanotechnology. Modi G; Pillay V; Choonara YE Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696 [TBL] [Abstract][Full Text] [Related]
6. Nanotechnology for neurodegenerative disorders. Re F; Gregori M; Masserini M Maturitas; 2012 Sep; 73(1):45-51. PubMed ID: 22261367 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective potential of cerium oxide nanoparticles for focal cerebral ischemic stroke. Zhou D; Fang T; Lu LQ; Yi L J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):480-486. PubMed ID: 27465320 [TBL] [Abstract][Full Text] [Related]
8. Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders. Nguyen TT; Nguyen-Thi PT; Nguyen THA; Ho TT; Tran NM; Van Vo T; Van Vo G Mol Diagn Ther; 2023 Jul; 27(4):457-473. PubMed ID: 37217723 [TBL] [Abstract][Full Text] [Related]
9. Redox nanoparticles: synthesis, properties and perspectives of use for treatment of neurodegenerative diseases. Sadowska-Bartosz I; Bartosz G J Nanobiotechnology; 2018 Nov; 16(1):87. PubMed ID: 30390681 [TBL] [Abstract][Full Text] [Related]
10. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases. Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453 [TBL] [Abstract][Full Text] [Related]
11. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders. Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594 [TBL] [Abstract][Full Text] [Related]
12. Yb Li Y; Li Y; Wang H; Liu R ACS Appl Mater Interfaces; 2021 Mar; 13(12):13968-13977. PubMed ID: 33739810 [TBL] [Abstract][Full Text] [Related]
13. Cerium oxide nanoparticles: applications and prospects in nanomedicine. Das S; Dowding JM; Klump KE; McGinnis JF; Self W; Seal S Nanomedicine (Lond); 2013 Sep; 8(9):1483-508. PubMed ID: 23987111 [TBL] [Abstract][Full Text] [Related]
14. [The role of steroid hormones in the neurodegenerative diseases]. Sadowska A; Grzesiak M Postepy Biochem; 2022 Dec; 68(4):387-398. PubMed ID: 36649137 [TBL] [Abstract][Full Text] [Related]
15. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment. Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771 [TBL] [Abstract][Full Text] [Related]
16. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases. Dhib-Jalbut S; Arnold DL; Cleveland DW; Fisher M; Friedlander RM; Mouradian MM; Przedborski S; Trapp BD; Wyss-Coray T; Yong VW J Neuroimmunol; 2006 Jul; 176(1-2):198-215. PubMed ID: 16983747 [TBL] [Abstract][Full Text] [Related]